BDBM620513 (3-Borono-5-(3-borono-5-(trifluoromethyl)benzoyl)benzoyl)glycine::US11767332, Example 19

SMILES OB(O)c1cc(cc(c1)C(=O)c1cc(cc(c1)C(F)(F)F)B(O)O)C(=O)NCC(O)=O

InChI Key InChIKey=NFDMEVUWFFHGTD-UHFFFAOYSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 620513   

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620513((3-Borono-5-(3-borono-5-(trifluoromethyl)benzoyl)b...)
Affinity DataKd:  1.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620513((3-Borono-5-(3-borono-5-(trifluoromethyl)benzoyl)b...)
Affinity DataKd:  1.70E+7nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent